Stroke risk in women: the role of menopause and hormone therapy.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 3615462)

Published in Lancet Neurol on January 01, 2012

Authors

Lynda Lisabeth1, Cheryl Bushnell

Author Affiliations

1: Department of Epidemiology, University of Michigan School of Public Health, Ann Arbour, MI, USA.

Associated clinical trials:

ELITE: Early Versus Late Intervention Trial With Estradiol | NCT00114517

Articles citing this

The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04

Sex differences in stroke. J Cereb Blood Flow Metab (2012) 1.21

Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008. Eur J Epidemiol (2012) 1.13

Cerebral hemodynamics in normal aging: central artery stiffness, wave reflection, and pressure pulsatility. J Cereb Blood Flow Metab (2014) 1.09

Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol (2013) 1.03

Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav (2012) 0.99

2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor. Eur J Pharmacol (2013) 0.92

Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol (2016) 0.90

Age at natural menopause in relation to all-cause and cause-specific mortality in a follow-up study of US black women. Maturitas (2013) 0.89

Stroke sensitivity in the aged: sex chromosome complement vs. gonadal hormones. Aging (Albany NY) (2016) 0.81

Symptomatic menopausal transition increases the risk of new-onset depressive disorder in later life: a nationwide prospective cohort study in Taiwan. PLoS One (2013) 0.80

Differences in Common Genetic Predisposition to Ischemic Stroke by Age and Sex. Stroke (2015) 0.79

Estrogen in ischaemic stroke: the debate continues. Eur J Neurol (2012) 0.77

Soluble epoxide hydrolase gene deletion improves blood flow and reduces infarct size after cerebral ischemia in reproductively senescent female mice. Front Pharmacol (2015) 0.77

Association between Menopausal Symptoms and Overactive Bladder: A Cross-Sectional Questionnaire Survey in China. PLoS One (2015) 0.75

Temporal and regional intestinal changes in permeability, tight junction, and cytokine gene expression following ovariectomy-induced estrogen deficiency. Physiol Rep (2017) 0.75

Gender-linked stem cell alterations in stroke and postpartum depression. CNS Neurosci Ther (2014) 0.75

Effects of estrogen on cerebrovascular function: age-dependent shifts from beneficial to detrimental in small cerebral arteries of the rat. Am J Physiol Heart Circ Physiol (2016) 0.75

Menopause and Ischemic Stroke: A Brief Review. MOJ Toxicol (2017) 0.75

Articles cited by this

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke (2010) 10.66

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50

Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol (1998) 5.54

Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet (2005) 5.38

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17

Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke (2001) 4.87

Stroke in a biracial population: the excess burden of stroke among blacks. Stroke (2004) 4.83

Incidence of premature ovarian failure. Obstet Gynecol (1986) 4.64

Molecular and cellular basis of cardiovascular gender differences. Science (2005) 4.37

Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13

A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med (2001) 3.86

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA (2011) 3.85

Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol (2009) 3.63

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63

The variability of female reproductive ageing. Hum Reprod Update (2002) 3.52

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Turner's syndrome. N Engl J Med (2004) 3.31

Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke (2009) 3.23

Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation (2005) 3.01

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation (2006) 2.40

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J (2008) 2.36

KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric (2005) 2.32

Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2003) 2.18

Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation (2001) 2.12

Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke (2005) 2.08

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab (2011) 2.02

Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause (2008) 1.94

Sex differences in first-ever acute stroke. Stroke (2003) 1.92

Age at natural menopause and risk of cardiovascular disease. Arch Intern Med (1999) 1.90

A midlife stroke surge among women in the United States. Neurology (2007) 1.86

Age at natural menopause and mortality. Ann Epidemiol (1998) 1.84

The role of genetic factors in age at natural menopause. Hum Reprod (2001) 1.83

Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation (2003) 1.71

Primary ovarian insufficiency. Lancet (2010) 1.67

A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas (1995) 1.67

Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995-1998. Stroke (2002) 1.62

Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA (2000) 1.61

Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol (2002) 1.58

Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke (2009) 1.57

Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke (2001) 1.55

Sex differences in stroke recovery and stroke-specific quality of life: results from a statewide stroke registry. Stroke (2007) 1.54

Ethnic disparities in stroke and hypertension among women: the BASIC project. Am J Hypertens (2008) 1.46

Age at natural menopause and cause-specific mortality. Am J Epidemiol (2005) 1.44

Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause (2006) 1.43

Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ (2005) 1.41

Relationships of age at menarche and menopause, and reproductive year with mortality from cardiovascular disease in Japanese postmenopausal women: the JACC study. J Epidemiol (2006) 1.38

Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ (2010) 1.32

Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem (1990) 1.31

Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab (2004) 1.29

Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med (2008) 1.21

Sex differences in acute stroke care in a statewide stroke registry. Stroke (2007) 1.18

Evidence for age-dependent education-related differences in men and women with first-ever stroke. Results from a community-based incidence study in northern Sweden. Neuroepidemiology (2007) 1.10

Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke (1998) 1.10

Risk of ischemic stroke and lifetime estrogen exposure. Neurology (2007) 1.09

Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arterioscler Thromb Vasc Biol (2011) 1.05

Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. Am J Epidemiol (2001) 1.05

The normal menopause transition: an overview. Maturitas (1996) 1.03

Hormone therapy and coronary heart disease in young women. Menopause (2008) 1.03

Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice. Atherosclerosis (2002) 1.00

Age at natural menopause and stroke mortality: cohort study with 3561 stroke deaths during 37-year follow-up. Stroke (2004) 0.99

EMAS position statement: Managing the menopause in the context of coronary heart disease. Maturitas (2010) 0.97

Stroke in Spain: epidemiologic incidence and patterns; a health sentinel network study. J Stroke Cerebrovasc Dis (2009) 0.96

Relationship between higher estradiol levels and 9-year mortality in older women: the Invecchiare in Chianti study. J Am Geriatr Soc (2009) 0.95

Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med (2004) 0.95

Young women have poorer outcomes than men after stroke. Cerebrovasc Dis (2011) 0.94

Prospective study of endogenous circulating estradiol and risk of stroke in older women. Arch Neurol (2010) 0.94

Hormone therapy and cardiovascular disease: a systematic review and meta-analysis. BJOG (2006) 0.92

Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. Fertil Steril (2007) 0.92

Premature menopause is associated with increased risk of cerebral infarction in Japanese women. Menopause (2010) 0.91

Persistent sex disparity in midlife stroke prevalence in the United States. Cerebrovasc Dis (2011) 0.88

Sex-specific temporal trends in in-hospital mortality after stroke among middle-age individuals in the United States. Stroke (2011) 0.88

Gender differences in stroke care and outcomes in Ontario. Womens Health Issues (2010) 0.87

Natural menopause and risk of stroke in elderly women. J Korean Med Sci (2005) 0.76

Articles by these authors

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16

Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48

Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89

Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50

Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69

Gene expression profiling of blood for the prediction of ischemic stroke. Stroke (2010) 1.61

NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies. Ann Emerg Med (2010) 1.24

Sedentary Behavior and Physical Function Decline in Older Women: Findings from the Women's Health Initiative. J Aging Res (2012) 1.23

Effects of gender on gene expression in the blood of ischemic stroke patients. J Cereb Blood Flow Metab (2011) 1.20

The X-chromosome has a different pattern of gene expression in women compared with men with ischemic stroke. Stroke (2011) 1.05

Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 0.97

Depression and antidepressant use after stroke and transient ischemic attack. Stroke (2012) 0.97

Pregnancy and stroke risk in women. Womens Health (Lond Engl) (2011) 0.91

Evaluation and management of cerebral venous thrombosis. Continuum (Minneap Minn) (2014) 0.83

The association between socioeconomic status and disability after stroke: findings from the Adherence eValuation After Ischemic stroke Longitudinal (AVAIL) registry. BMC Public Health (2014) 0.83

Y chromosome gene expression in the blood of male patients with ischemic stroke compared with male controls. Gend Med (2012) 0.82

Systematic stroke prevention. Continuum (Minneap Minn) (2011) 0.82

Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline. Ann Intern Med (2014) 0.82

Education research: neurology continuity clinic. Improving the timing of the experience. Neurology (2009) 0.81

Medication coaching program for patients with minor stroke or TIA: a pilot study. BMC Public Health (2012) 0.81

Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep (2010) 0.80

Reducing stroke in women with risk factor management: blood pressure and cholesterol. Womens Health (Lond Engl) (2014) 0.79

A comparative analysis of risk factors for stroke in blacks and whites: the Atherosclerosis Risk in Communities study. Ethn Health (2013) 0.77

Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn) (2017) 0.77

Secondary prevention of stroke in the elderly: focus on drug therapy. Drugs Aging (2014) 0.77

Depression and the risk of stroke in women: an identification and treatment paradox. Stroke (2011) 0.76

Another score to predict ischemic stroke mortality? Circulation (2011) 0.76

Contemporary management of migrainous disorders in pregnancy. Curr Opin Obstet Gynecol (2010) 0.75

Excellence in stroke care: improving care in community hospitals. Hosp Health Netw (2012) 0.75

An evaluation of stroke education in AVAIL registry hospitals. J Neurosci Nurs (2012) 0.75

Cheryl Bushnell. Lancet Neurol (2012) 0.75